Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism

Abstract Context The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. Objective To assess the clinical, biochemical, and radiological profile of NHPT comp...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 105; no. 7; pp. e2609 - e2616
Main Authors Palermo, Andrea, Naciu, Anda Mihaela, Tabacco, Gaia, Falcone, Stefania, Santonati, Assunta, Maggi, Daria, D’Onofrio, Luca, Briganti, Silvia Irina, Castellitto, Domenico, Casini, Alessandro, Pedone, Claudio, Lelli, Diana, Fabbri, Andrea, Bilezikian, John P, Napoli, Nicola, Pozzilli, Paolo, Manfrini, Silvia, Cesareo, Roberto
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.07.2020
Copyright Oxford University Press
Subjects
Online AccessGet full text
ISSN0021-972X
1945-7197
1945-7197
DOI10.1210/clinem/dgaa174

Cover

Abstract Abstract Context The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. Objective To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects Design Multicentric cross-sectional study Setting Outpatient clinic Patients 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects. Main Outcome Measures Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry. Results NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate–severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism. Conclusions The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.
AbstractList The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects. Multicentric cross-sectional study. Outpatient clinic. 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects. Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry. NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism. The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.
The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.CONTEXTThe clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size.To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.OBJECTIVETo assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects.Multicentric cross-sectional study.DESIGNMulticentric cross-sectional study.Outpatient clinic.SETTINGOutpatient clinic.47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.PATIENTS47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects.Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.MAIN OUTCOME MEASURESCalcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry.NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.RESULTSNHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism.The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.CONCLUSIONSThe biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.
Abstract Context The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. Objective To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects Design Multicentric cross-sectional study Setting Outpatient clinic Patients 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects. Main Outcome Measures Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry. Results NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate–severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism. Conclusions The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.
Author Santonati, Assunta
Lelli, Diana
Bilezikian, John P
Maggi, Daria
Pedone, Claudio
Naciu, Anda Mihaela
Napoli, Nicola
Tabacco, Gaia
Manfrini, Silvia
D’Onofrio, Luca
Casini, Alessandro
Cesareo, Roberto
Briganti, Silvia Irina
Pozzilli, Paolo
Palermo, Andrea
Castellitto, Domenico
Falcone, Stefania
Fabbri, Andrea
AuthorAffiliation Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy Unit of Geriatric, University Campus Bio-Medico, Rome, Italy Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, NY, USA
AuthorAffiliation_xml – name: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy Unit of Geriatric, University Campus Bio-Medico, Rome, Italy Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, NY, USA
Author_xml – sequence: 1
  givenname: Andrea
  surname: Palermo
  fullname: Palermo, Andrea
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 2
  givenname: Anda Mihaela
  surname: Naciu
  fullname: Naciu, Anda Mihaela
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 3
  givenname: Gaia
  orcidid: 0000-0002-6808-0700
  surname: Tabacco
  fullname: Tabacco, Gaia
  email: g.tabacco@unicampus.it
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 4
  givenname: Stefania
  surname: Falcone
  fullname: Falcone, Stefania
  organization: Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy
– sequence: 5
  givenname: Assunta
  surname: Santonati
  fullname: Santonati, Assunta
  organization: Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy
– sequence: 6
  givenname: Daria
  surname: Maggi
  fullname: Maggi, Daria
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 7
  givenname: Luca
  surname: D’Onofrio
  fullname: D’Onofrio, Luca
  organization: Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
– sequence: 8
  givenname: Silvia Irina
  surname: Briganti
  fullname: Briganti, Silvia Irina
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 9
  givenname: Domenico
  surname: Castellitto
  fullname: Castellitto, Domenico
  organization: UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy
– sequence: 10
  givenname: Alessandro
  surname: Casini
  fullname: Casini, Alessandro
  organization: UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy
– sequence: 11
  givenname: Claudio
  surname: Pedone
  fullname: Pedone, Claudio
  organization: Geriatric Unit, University Campus Bio-Medico, Rome, Italy
– sequence: 12
  givenname: Diana
  surname: Lelli
  fullname: Lelli, Diana
  organization: Geriatric Unit, University Campus Bio-Medico, Rome, Italy
– sequence: 13
  givenname: Andrea
  surname: Fabbri
  fullname: Fabbri, Andrea
  organization: Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy
– sequence: 14
  givenname: John P
  surname: Bilezikian
  fullname: Bilezikian, John P
  organization: Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, New York
– sequence: 15
  givenname: Nicola
  surname: Napoli
  fullname: Napoli, Nicola
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 16
  givenname: Paolo
  orcidid: 0000-0001-5090-636X
  surname: Pozzilli
  fullname: Pozzilli, Paolo
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 17
  givenname: Silvia
  surname: Manfrini
  fullname: Manfrini, Silvia
  organization: Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
– sequence: 18
  givenname: Roberto
  surname: Cesareo
  fullname: Cesareo, Roberto
  organization: UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32271382$$D View this record in MEDLINE/PubMed
BookMark eNqFkEtr3DAURkVISCaPbZbFywbqRK-JpGUztE0htKWk0EVAXMvXGbWy5Ug2Yf59PXiyCYSuhO79zidxjsl-Fzsk5JzRS8YZvXLBd9he1Y8ATMk9smBGLkvFjNonC0o5K43iv4_Icc5_KGVSLsUhORKcKyY0X5CH1VTgHYQPxY2Pbo3tfIGuLn5C7WOIj9tJ8SPFxgcsYlN8i6mN08xtw9PCt5A2xe2mx9RDgmG9SdHXPren5KCBkPFsd56QX58_3a9uy7vvX76uPt6VTiguS6WM1ooh07WWrFJglgZF1dSuAacdVOAkkzUH0Ti-5NxUyA1VBqcdu5ZGnJD3c2-f4tOIebCtzw5DgA7jmC0XWk8uhKZT9N0uOlYt1raff29fjEwBOQdcijknbKzzAww-dkMCHyyjdivezuLtTvyEXb7CXprfBPgMPMcwYMp_w_iMya4RwrB-G7qYoTj2_3vgH5HnqRI
CitedBy_id crossref_primary_10_1007_s12020_021_02845_4
crossref_primary_10_3390_jcm13216325
crossref_primary_10_1016_j_mcna_2021_05_017
crossref_primary_10_1210_jendso_bvad013
crossref_primary_10_1007_s11154_020_09614_0
crossref_primary_10_22141_2224_0721_17_5_2021_241515
crossref_primary_10_3803_EnM_2021_1061
crossref_primary_10_33145_2304_8336_2024_29_44_66
crossref_primary_10_4158_EP_2020_0405
crossref_primary_10_1007_s11154_024_09899_5
crossref_primary_10_1016_j_eprac_2023_12_004
crossref_primary_10_1016_j_eprac_2021_04_884
crossref_primary_10_1002_jbm4_10391
crossref_primary_10_1210_clinem_dgad256
crossref_primary_10_1002_hed_26861
crossref_primary_10_23736_S1824_4785_23_03510_0
crossref_primary_10_3346_jkms_2022_37_e99
crossref_primary_10_1177_2042018821995370
crossref_primary_10_3389_fendo_2024_1428640
crossref_primary_10_1016_j_amjsurg_2024_03_007
crossref_primary_10_1093_jbmrpl_ziae074
crossref_primary_10_3389_fmicb_2023_1124945
crossref_primary_10_7759_cureus_64988
crossref_primary_10_20945_2359_4292_2023_0315
crossref_primary_10_1210_clinem_dgae659
crossref_primary_10_1007_s40618_020_01269_7
crossref_primary_10_1210_clinem_dgae239
crossref_primary_10_1007_s00405_021_06953_9
crossref_primary_10_1007_s13304_021_01108_1
crossref_primary_10_1007_s00198_023_06669_y
crossref_primary_10_1007_s12020_023_03491_8
crossref_primary_10_1210_clinem_dgab240
crossref_primary_10_20945_2359_3997000000557
crossref_primary_10_20945_2359_3997000000556
crossref_primary_10_1002_jbmr_4679
crossref_primary_10_1007_s40619_023_01263_0
crossref_primary_10_1177_20406223211015965
crossref_primary_10_3390_pathogens12020184
crossref_primary_10_1007_s12020_023_03476_7
crossref_primary_10_3390_ijms222312975
crossref_primary_10_1007_s12020_020_02545_5
crossref_primary_10_1007_s12262_022_03420_5
Cites_doi 10.1210/jc.2003-031014
10.1530/EC-15-0030
10.1590/S0004-27302011000500003
10.1530/eje.1.02225
10.1016/S0039-6060(97)90357-3
10.1210/jc.2013-1300
10.1007/s12020-012-9694-z
10.1159/000502578
10.1007/s00198-014-3000-2
10.1155/2012/128352
10.1210/jc.2007-1215
10.1210/jc.2002-021404
10.1007/s00198-005-2010-5
10.1210/jc.2014-1414
10.1111/cen.12819
10.1210/jc.2008-1763
10.4158/EP151055.OR
10.1210/jc.2014-1413
10.1002/jbmr.5650080915
10.1210/jc.2008-1758
10.1016/j.amjmed.2004.06.037
10.1210/jc.2006-2802
10.1056/NEJM196605262742105
10.1007/s00774-015-0673-3
10.1016/j.jocd.2012.12.001
10.1530/EJE-13-0305
10.1007/s42000-018-0069-6
10.1007/s00268-018-4512-2
10.1038/nrdp.2016.33
10.7326/0003-4819-130-6-199903160-00002
10.1210/jc.2014-1415
10.1056/NEJM199910213411701
10.1210/jc.2013-1518
10.1111/j.1365-2796.2004.01422.x
10.4081/reumatismo.2016.870
10.1007/s00223-010-9454-0
10.1016/S0140-6736(17)31430-7
10.1097/MED.0000000000000198
ContentType Journal Article
Copyright Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020
Copyright © Oxford University Press 2015
Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Copyright_xml – notice: Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020
– notice: Copyright © Oxford University Press 2015
– notice: Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1210/clinem/dgaa174
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage e2616
ExternalDocumentID 32271382
10_1210_clinem_dgaa174
10.1210/clinem/dgaa174
Genre Journal Article
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
3O-
3V.
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAPGJ
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABBLC
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABSAR
ABWST
ABXVV
ACFRR
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ACZBC
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
ADZCM
AELWJ
AEMDU
AENEX
AENZO
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGQXC
AGUTN
AHMBA
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ASPBG
ATGXG
AVNTJ
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EIHJH
EJD
EMOBN
ENERS
F5P
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
G8K
GAUVT
GJXCC
GX1
H13
HVGLF
HZ~
H~9
IAO
IHR
INH
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MBLQV
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
PQQKQ
PROAC
REU
ROX
ROZ
TEORI
TJX
TLC
TMA
TR2
TWZ
VH1
VVN
W8F
WHG
WOQ
X52
X7M
YBU
YFH
YHG
YOC
YSK
ZGI
ZXP
ZY1
~02
~H1
7X7
88E
8FI
8FJ
ABDFA
ABEJV
ABGNP
ABUWG
ABVGC
ABXZS
ADNBA
AEMQT
AEOTA
AFKRA
AGORE
AHGBF
AHMMS
AJBYB
ALXQX
CCPQU
FYUFA
HMCUK
ITC
M1P
NU-
PHGZM
PHGZT
PSQYO
UKHRP
AAYXX
AEHZK
CITATION
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3724-7798871e18d841b7a959e3bfdcfac8cabac414d2a3fc25229be29079e8ca16493
ISSN 0021-972X
1945-7197
IngestDate Sat Sep 27 19:54:40 EDT 2025
Mon Jul 21 06:08:11 EDT 2025
Thu Apr 24 23:07:07 EDT 2025
Wed Oct 01 01:54:22 EDT 2025
Fri May 16 03:56:34 EDT 2025
Wed Aug 28 03:18:41 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords hypercalcemia
normocalcemic
calcium
PTH
Hyperparathyroidism
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3724-7798871e18d841b7a959e3bfdcfac8cabac414d2a3fc25229be29079e8ca16493
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5090-636X
0000-0002-6808-0700
PMID 32271382
PQID 2388002380
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2388002380
pubmed_primary_32271382
crossref_citationtrail_10_1210_clinem_dgaa174
crossref_primary_10_1210_clinem_dgaa174
wolterskluwer_health_10_1210_clinem_dgaa174
oup_primary_10_1210_clinem_dgaa174
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-01
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-01
  day: 01
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2020
Publisher Oxford University Press
Copyright Oxford University Press
Publisher_xml – name: Oxford University Press
– name: Copyright Oxford University Press
References Eastell (2021122116122941000_CIT0009) 2014; 99
Silverberg (2021122116122941000_CIT0012) 2003; 88
Tordjman (2021122116122941000_CIT0016) 2004; 117
Anastasilakis (2021122116122941000_CIT0011) 2019; 18
Díaz-Soto (2021122116122941000_CIT0032) 2016; 22
Pawlowska (2021122116122941000_CIT0036) 2015; 22
Bilezikian (2021122116122941000_CIT0021) 2018; 391
Kontogeorgos (2021122116122941000_CIT0028) 2015; 83
Levey (2021122116122941000_CIT0022) 1999; 130
Tuna (2021122116122941000_CIT0035) 2016; 34
Díaz-Soto (2021122116122941000_CIT0030) 2016; 48
Bilezikian (2021122116122941000_CIT0001) 2016; 2
Eastell (2021122116122941000_CIT0008) 2009; 94
Cesareo (2021122116122941000_CIT0018) 2015; 26
Cusano (2021122116122941000_CIT0014) 2013; 16
Cope (2021122116122941000_CIT0003) 1966; 274
Bilezikian (2021122116122941000_CIT0006) 2005; 257
Bilezikian (2021122116122941000_CIT0017) 2014; 99
Calcium calculator IOF (2021122116122941000_CIT0020)
García-Martín (2021122116122941000_CIT0015) 2012; 42
Genant (2021122116122941000_CIT0024) 1993; 8
Vignali (2021122116122941000_CIT0027) 2015; 4
Amaral (2021122116122941000_CIT0034) 2012; 2012
Kiriakopoulos (2021122116122941000_CIT0033) 2018; 42
Rossini (2021122116122941000_CIT0019) 2016; 68
Silverberg (2021122116122941000_CIT0005) 1999; 341
Lemos (2021122116122941000_CIT0041) 2019;44(5):1189-1195
Rubin (2021122116122941000_CIT0004) 2008; 93
Lundgren (2021122116122941000_CIT0026) 1997; 121
Maruani (2021122116122941000_CIT0013) 2003; 88
Eller-Vainicher (2021122116122941000_CIT0039) 2013; 169
Schousboe (2021122116122941000_CIT0023) 2006; 17
Silverberg (2021122116122941000_CIT0002) 2014; 99
Koumakis (2021122116122941000_CIT0037) 2013; 98
Marques (2021122116122941000_CIT0029) 2011; 55
Bilezikian (2021122116122941000_CIT0007) 2009; 94
Cusano (2021122116122941000_CIT0010) 2013; 98
Cohen (2021122116122941000_CIT0025) 1988
De Geronimo (2021122116122941000_CIT0040) 2006; 155
Lowe (2021122116122941000_CIT0031) 2007; 92
Rejnmark (2021122116122941000_CIT0038) 2011; 88
References_xml – volume: 88
  start-page: 5348
  issue: 11
  year: 2003
  ident: 2021122116122941000_CIT0012
  article-title: “Incipient” primary hyperparathyroidism: a “forme fruste” of an old disease
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2003-031014
– volume: 4
  start-page: 172
  issue: 3
  year: 2015
  ident: 2021122116122941000_CIT0027
  article-title: Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy
  publication-title: Endocr Connect.
  doi: 10.1530/EC-15-0030
– volume: 55
  start-page: 314
  issue: 5
  year: 2011
  ident: 2021122116122941000_CIT0029
  article-title: Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?
  publication-title: Arq Bras Endocrinol Metabol.
  doi: 10.1590/S0004-27302011000500003
– volume: 155
  start-page: 415
  issue: 3
  year: 2006
  ident: 2021122116122941000_CIT0040
  article-title: The risk of fractures in postmenopausal women with primary hyperparathyroidism
  publication-title: Eur J Endocrinol.
  doi: 10.1530/eje.1.02225
– volume: 121
  start-page: 287
  issue: 3
  year: 1997
  ident: 2021122116122941000_CIT0026
  article-title: Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women
  publication-title: Surgery.
  doi: 10.1016/S0039-6060(97)90357-3
– volume: 98
  start-page: 2734
  issue: 7
  year: 2013
  ident: 2021122116122941000_CIT0010
  article-title: Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2013-1300
– volume: 42
  start-page: 764
  issue: 3
  year: 2012
  ident: 2021122116122941000_CIT0015
  article-title: Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women
  publication-title: Endocrine.
  doi: 10.1007/s12020-012-9694-z
– year: 2019;44(5):1189-1195
  ident: 2021122116122941000_CIT0041
  article-title: High rate of occult urolithiasis in normocalcemic primary hyperparathyroidism
  publication-title: Kidney Blood Press. Res.
  doi: 10.1159/000502578
– volume: 26
  start-page: 1295
  issue: 4
  year: 2015
  ident: 2021122116122941000_CIT0018
  article-title: Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
  publication-title: Osteoporos Int.
  doi: 10.1007/s00198-014-3000-2
– volume: 2012
  start-page: 128352
  year: 2012
  ident: 2021122116122941000_CIT0034
  article-title: Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?
  publication-title: J Osteoporos.
  doi: 10.1155/2012/128352
– volume: 93
  start-page: 3462
  issue: 9
  year: 2008
  ident: 2021122116122941000_CIT0004
  article-title: The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2007-1215
– volume: 88
  start-page: 4641
  issue: 10
  year: 2003
  ident: 2021122116122941000_CIT0013
  article-title: Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2002-021404
– volume: 17
  start-page: 281
  issue: 2
  year: 2006
  ident: 2021122116122941000_CIT0023
  article-title: Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice
  publication-title: Osteoporos Int.
  doi: 10.1007/s00198-005-2010-5
– volume: 48
  start-page: 163
  issue: 3
  year: 2016
  ident: 2021122116122941000_CIT0030
  article-title: Clinical expression of calcium sensing receptor polymorphism (A986S) in normocalcemic and asymptomatic hyperparathyroidism
  publication-title: Horm Metab Res.
– volume: 99
  start-page: 3570
  issue: 10
  year: 2014
  ident: 2021122116122941000_CIT0009
  article-title: Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2014-1414
– volume: 83
  start-page: 277
  issue: 2
  year: 2015
  ident: 2021122116122941000_CIT0028
  article-title: Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden
  publication-title: Clin Endocrinol (Oxf).
  doi: 10.1111/cen.12819
– ident: 2021122116122941000_CIT0020
– volume: 94
  start-page: 335
  issue: 2
  year: 2009
  ident: 2021122116122941000_CIT0007
  article-title: Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2008-1763
– volume: 22
  start-page: 703
  issue: 6
  year: 2016
  ident: 2021122116122941000_CIT0032
  article-title: Trabecular bone score in patients with normocalcemic hyperparathyroidism
  publication-title: Endocr Pract.
  doi: 10.4158/EP151055.OR
– volume: 99
  start-page: 3561
  issue: 10
  year: 2014
  ident: 2021122116122941000_CIT0017
  article-title: Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2014-1413
– volume: 8
  start-page: 1137
  issue: 9
  year: 1993
  ident: 2021122116122941000_CIT0024
  article-title: Vertebral fracture assessment using a semiquantitative technique
  publication-title: J Bone Miner Res.
  doi: 10.1002/jbmr.5650080915
– volume: 94
  start-page: 340
  issue: 2
  year: 2009
  ident: 2021122116122941000_CIT0008
  article-title: Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2008-1758
– volume: 117
  start-page: 861
  issue: 11
  year: 2004
  ident: 2021122116122941000_CIT0016
  article-title: Characterization of normocalcemic primary hyperparathyroidism
  publication-title: Am J Med.
  doi: 10.1016/j.amjmed.2004.06.037
– volume: 92
  start-page: 3001
  issue: 8
  year: 2007
  ident: 2021122116122941000_CIT0031
  article-title: Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2006-2802
– volume: 274
  start-page: 1174
  issue: 21
  year: 1966
  ident: 2021122116122941000_CIT0003
  article-title: The study of hyperparathyroidism at the Massachusetts General Hospital
  publication-title: N Engl J Med.
  doi: 10.1056/NEJM196605262742105
– volume: 34
  start-page: 331
  issue: 3
  year: 2016
  ident: 2021122116122941000_CIT0035
  article-title: Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism
  publication-title: J Bone Miner Metab.
  doi: 10.1007/s00774-015-0673-3
– volume: 16
  start-page: 33
  issue: 1
  year: 2013
  ident: 2021122116122941000_CIT0014
  article-title: Normocalcemic primary hyperparathyroidism
  publication-title: J Clin Densitom.
  doi: 10.1016/j.jocd.2012.12.001
– volume: 169
  start-page: 155
  issue: 2
  year: 2013
  ident: 2021122116122941000_CIT0039
  article-title: Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism
  publication-title: Eur J Endocrinol.
  doi: 10.1530/EJE-13-0305
– volume: 18
  start-page: 65
  issue: 1
  year: 2019
  ident: 2021122116122941000_CIT0011
  article-title: Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview
  publication-title: Hormones (Athens).
  doi: 10.1007/s42000-018-0069-6
– volume: 42
  start-page: 992
  issue: 4
  year: 2018
  ident: 2021122116122941000_CIT0033
  article-title: Classic primary hyperparathyroidism versus normocalcemic and normohormonal variants: do they really differ?
  publication-title: World J Surg.
  doi: 10.1007/s00268-018-4512-2
– volume: 2
  start-page: 16033
  year: 2016
  ident: 2021122116122941000_CIT0001
  article-title: Primary hyperparathyroidism
  publication-title: Nat Rev Dis Primers.
  doi: 10.1038/nrdp.2016.33
– volume: 130
  start-page: 461
  issue: 6
  year: 1999
  ident: 2021122116122941000_CIT0022
  article-title: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
  publication-title: Ann Intern Med.
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 99
  start-page: 3580
  issue: 10
  year: 2014
  ident: 2021122116122941000_CIT0002
  article-title: Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2014-1415
– start-page: 1
  volume-title: The concept of Power analysis in Statistical Power Analysis for the Behavioral Sciences
  year: 1988
  ident: 2021122116122941000_CIT0025
– volume: 341
  start-page: 1249
  issue: 17
  year: 1999
  ident: 2021122116122941000_CIT0005
  article-title: A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
  publication-title: N Engl J Med.
  doi: 10.1056/NEJM199910213411701
– volume: 98
  start-page: 3213
  issue: 8
  year: 2013
  ident: 2021122116122941000_CIT0037
  article-title: Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2013-1518
– volume: 257
  start-page: 6
  issue: 1
  year: 2005
  ident: 2021122116122941000_CIT0006
  article-title: Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features
  publication-title: J Intern Med.
  doi: 10.1111/j.1365-2796.2004.01422.x
– volume: 68
  start-page: 1
  issue: 1
  year: 2016
  ident: 2021122116122941000_CIT0019
  article-title: Guidelines for the diagnosis, prevention and management of osteoporosis
  publication-title: Reumatismo
  doi: 10.4081/reumatismo.2016.870
– volume: 88
  start-page: 238
  issue: 3
  year: 2011
  ident: 2021122116122941000_CIT0038
  article-title: Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study
  publication-title: Calcif Tissue Int.
  doi: 10.1007/s00223-010-9454-0
– volume: 391
  start-page: 168
  issue: 10116
  year: 2018
  ident: 2021122116122941000_CIT0021
  article-title: Hyperparathyroidism
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(17)31430-7
– volume: 22
  start-page: 413
  issue: 6
  year: 2015
  ident: 2021122116122941000_CIT0036
  article-title: An overview of normocalcemic primary hyperparathyroidism
  publication-title: Curr Opin Endocrinol Diabetes Obes.
  doi: 10.1097/MED.0000000000000198
SSID ssj0014453
Score 2.5199752
Snippet Abstract Context The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out...
The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary...
SourceID proquest
pubmed
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e2609
SubjectTerms Absorptiometry, Photon
Aged
Biomarkers - blood
Bone Density - physiology
Calcium - blood
Cross-Sectional Studies
Female
Femur Neck - diagnostic imaging
Humans
Hyperparathyroidism, Primary - blood
Hyperparathyroidism, Primary - diagnostic imaging
Lumbar Vertebrae - diagnostic imaging
Male
Middle Aged
Parathyroid Hormone - blood
Vitamin D - analogs & derivatives
Vitamin D - blood
Title Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism
URI https://www.ncbi.nlm.nih.gov/pubmed/32271382
https://www.proquest.com/docview/2388002380
Volume 105
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1945-7197
  dateEnd: 20241002
  omitProxy: true
  ssIdentifier: ssj0014453
  issn: 0021-972X
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1945-7197
  dateEnd: 20241002
  omitProxy: true
  ssIdentifier: ssj0014453
  issn: 0021-972X
  databaseCode: GX1
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1945-7197
  dateEnd: 20211231
  omitProxy: true
  ssIdentifier: ssj0014453
  issn: 0021-972X
  databaseCode: 7X7
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1945-7197
  dateEnd: 20211231
  omitProxy: true
  ssIdentifier: ssj0014453
  issn: 0021-972X
  databaseCode: BENPR
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6TkIghLhTLlNASDxsGXHixPEjoJUKqdWEOqkPSJFjOxDYEtS1QvDL-Hkcx46bQCcGL1Hjy0mT8-Ucn_hcEHquQZCEmPixkMonvFA-By3rC5kEkjKBcRPlOp0lkxPybhEvBoOfHa-l9So_FD-2xpX8D1ehDfiqo2T_gbOOKDTAb-AvHIHDcLwUj21ST7NxUOraV2ftaRN3yGXpZNuxKc7dfCGAdapWYcI4xtt8ExOwSJdNJvBP35d1Kdvcgp83eOqkmXARlaqSNUieapPL6UytAFmn7XxTpAUUQO0cKJ0qmHFRrm0z35-W2oPfdc55zoVoZr3lpWsec72HpqyLWsEr22U_XYCd2rq5bkIJsM9oU08dlJGRwIzEPsXGadeJ6CDuYJF2BK4Ce4x1tDecm9jNP1QD2LbAT_10FLxpY_mRc2wKBPWzcP-mHZ3PoraWgEZmKGR2_g7aDWmShEO0-_podvze7WARYjOg2lu0CUN1xJSh8NJS6C2IekGWHVvnGrr-rdbuE-dfmuiJzhpofhPdsMaL98og8RYaqOo2ujK17hl30IcWkAdeB44HHqDC64LRs2D06sLrgdGzYPS2gPEuOhkfzd9MfFu-wxcRDQnYbQw0GFY4lSnBOeUsZirKCykKLlKhMUQwkSGPChGCGcByFbKAMgV9YMSz6B4aVoCnB8gTCsyYCBcJ45gEsILCQiQc9LRIo1QWZIT89hlmwua21yVWTrPtXBuhF278V3NjF458Biz566CnLccykM56y41Xql6fZ6HOtaSXxcEI3TesdLRAlVKdAXSE9nu8zUwE9AXXenjpv_4IXd28dI_RcLVcqyewgl7le2iHLuiehewvfAbP7w
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical%2C+Biochemical%2C+and+Radiological+Profile+of+Normocalcemic+Primary+Hyperparathyroidism&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Palermo%2C+Andrea&rft.au=Naciu%2C+Anda+Mihaela&rft.au=Tabacco%2C+Gaia&rft.au=Falcone%2C+Stefania&rft.date=2020-07-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=105&rft.issue=7&rft.spage=e2609&rft.epage=e2616&rft_id=info:doi/10.1210%2Fclinem%2Fdgaa174&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_clinem_dgaa174
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon